Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
International Journal of Medical Sciences , 07/08/09
Tokumura A et al. - Serum LPA:LPC ratios of two different polyunsaturated phospholipid molecular species, and also the ratio of all species combined, were significantly higher in SSc subjects versus controls. No significant differences were found between other lysophospholipid levels or lysoPLD activities. Elevated 20:4 LPA, S1P levels and polyunsaturated LPA:LPC ratios may be markers for and/or play a significant role in the etiology of SSc and may be future pharmacological targets for SSc treatment.
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Echocardiography as an Outcome Measure in Scleroderma-related Pulmonary Arterial Hypertension: Results of a Systematic Literature Analysis by the EPOSS Group
Journal of Rheumatology, 12/08/09
Depletion of functionally active CD20+ T cells by rituximab treatment
Arthritis & Rheumatism, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


